Advanced Accelerator Applications develops, produces and commercializes drugs for targeted radioligand therapy and precision radioligand imaging.

Our expertise is built on a more than 15-year legacy of manufacturing and commercializing a portfolio of PET and SPECT nuclear medicine imaging products for a number of indications in oncology, neurology, cardiology and infectious & inflammatory diseases.